TCL Archive AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm May 8, 2013
TCL Archive NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests June 5, 1992
TCL Archive Cancer Leadership Council letter calls for permanent leadership of NCI and FDA. November 23, 2005